Devonian Health Group Inc.
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis as… Read more
Devonian Health Group Inc. (DVHGF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of October 2025: -0.245x
Based on the latest financial reports, Devonian Health Group Inc. (DVHGF) has a cash flow conversion efficiency ratio of -0.245x as of October 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.35 Million) by net assets ($9.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Devonian Health Group Inc. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Devonian Health Group Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Devonian Health Group Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Devonian Health Group Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oceanpal Inc
NASDAQ:OP
|
-0.007x |
|
H&K AG
PA:MLHK
|
0.239x |
|
Global X Silver Miners UCITS ETF USD Acc
F:SLVR
|
N/A |
|
EDESAL Holding SA
BA:EDLH
|
0.159x |
|
Føroya Banki
F:BNW
|
-0.235x |
|
EXLSERVICE HLDG
BE:LHV
|
0.121x |
|
First National Energy Corp
PINK:FNEC
|
0.000x |
|
2G ENERGY
BE:2GB
|
N/A |
Annual Cash Flow Conversion Efficiency for Devonian Health Group Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Devonian Health Group Inc. from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | $9.14 Million | $-1.25 Million | -0.137x | -135.05% |
| 2024-07-31 | $14.46 Million | $5.63 Million | 0.390x | +227.41% |
| 2023-07-31 | $14.25 Million | $-4.36 Million | -0.306x | -73.26% |
| 2022-07-31 | $16.27 Million | $-2.87 Million | -0.176x | +27.58% |
| 2021-07-31 | $7.52 Million | $-1.83 Million | -0.244x | -12.78% |
| 2020-07-31 | $9.38 Million | $-2.03 Million | -0.216x | -88.03% |
| 2019-07-31 | $10.08 Million | $-1.16 Million | -0.115x | -- |